Shares of Opko Health Inc. (NYSE:OPK) ended Friday session in green amid volatile trading. The shares closed up +0.20 points or 2.09% at $9.75 with 3.33 million shares getting traded. Post opening the session at $9.56, the shares hit an intraday low of $9.55 and an intraday high of $9.90 and the price vacillated in this range throughout the day. The company has a market cap of $5.13 billion and the numbers of outstanding shares have been calculated to be 547.44 million shares.
Opko Health Inc. (OPK) on May 11, 2016 announced the appointment of Douglass Laidlaw, PhD as Vice President of Medical Affairs to support the anticipated launch of RAYALDEE®.
Dr. Laidlaw has over 15 years of experience in leading strategic planning, development and execution of medical education initiatives for numerous pharmaceutical companies, including Relypsa, Keryx, Sanofi, Genzyme, Neurocine Biosciences, Serono and Organon. He has been involved in new product launches targeting patients with chronic kidney disease and has deep connections with key nephrology opinion leaders. Prior to joining OPKO, Dr. Laidlaw served as Relypsa’s Executive Director, Medical Affairs, and Sanofi’s National Director, Medical Science Liaisons, Medical Affairs.
“Doug is a key addition to the management team in OPKO’s Renal Division,” said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO. “A well-conceived and executed medical education strategy is critical to Rayaldee’s acceptance by U.S. healthcare professionals.”
Shares of Palatin Technologies, Inc. (NYSEMKT:PTN) closed at $0.525 with 177,620.00 shares getting traded. Post opening the session at $0.54, the shares hit an intraday low of $0.52 and an intraday high of $0.59 and the price vacillated in this range throughout the day. The company has a market cap of $34.66 million and the numbers of outstanding shares have been calculated to be 68.04 million shares.
Palatin Technologies, Inc. (PTN) on May 12, 2016 announced that it will release third quarter, fiscal year 2016 operating results on Tuesday, May 17, 2016 before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 17, 2016 at 11:00 a.m. ET. The conference call will include a review of the company’s operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Webcast
Q3 Fiscal Year 2016 Financial Results Press Release 5/17/2016 at 7:30 a.m. ET
Q3 Fiscal Year 2016 Conference Call-Live 5/17/2016 at 11:00 a.m. ET
Domestic Dial-In Number 1-800-524-8850
International Dial-In Number 1-416-204-9702
Passcode 9763497
Q3 Fiscal Year 2016 Conference Call-Replay 5/17/2016-5/24/2016
Domestic Dial-In Number 1-888-203-1112
International Dial-In Number 1-719-457-0820
Passcode 9763497
Webcast Live and Replay Access http://www.palatin.com
The webcast and replay can be accessed by logging on to the “Investors-Webcasts” section of Palatin’s website at http://www.palatin.com.
Shares of Gilead Sciences, Inc. (NASDAQ:GILD) ended Friday session in red amid volatile trading. The shares closed down -0.06 points or -0.07% at $82.70 with 8.33 million shares getting traded. Post opening the session at $82.66, the shares hit an intraday low of $82.41 and an intraday high of $83.87 and the price vacillated in this range throughout the day. The company has a market cap of $108.65 billion and the numbers of outstanding shares have been calculated to be 1.33 billion shares.
Gilead Sciences, Inc. (GILD) on April 28, 2016 announced that its Board of Directors has declared a cash dividend of $0.47 per share of common stock for the second quarter of 2016. The dividend is payable on June 29, 2016, to stockholders of record at the close of business on June 16, 2016. Future dividends will be subject to Board approval.